Table 2.
Frequency of Participant-Clinician Communication and Documentation about Chemotherapy-Induced Peripheral Neuropathy (CIPN) Symptoms (N = 159)
| Assessment Characteristics | Frequency (%) |
|---|---|
| CIPN Documentation (n = 73) | |
| - Non-Painful CIPN Documentationa | 70 (96%) |
| - Painful CIPN Documentationa | 37 (51%) |
| - Motor CIPN Documentationa | 43 (59%) |
| Participant-Clinician Discussion of CIPN Symptoms (n = 70) | |
| - CIPN Discussion Initiated by Participant or Caregiverb | 26 (37%) |
| - CIPN Discussion Initiated by Clinicianb | 44 (63%) |
| Participant Reported CIPN Symptoms (n = 44) | |
| - Non-Painful CIPN Symptom Intensity Discussionc | 8 (18%) |
| - Painful CIPN Symptom Intensity Discussionc | 5 (11%) |
| - Motor CIPN Symptom Discussionc | 15 (34%) |
| - Discuss at Least One Aspect of OPQRT (Onset, Provocation, Palliation, Quality, Location, Radiation, Time History)c | 32 (73%) |
| - Clinician Acknowledged Participant’s CIPN Reportc | 7 (16%) |
| - Clinician Acknowledged and Explored Participant’s CIPN Reportc | 34 (77%) |
| - Clinician Dismissed Participant’s CIPN Reportc | 3 (7%) |
a
Frequency (%) was calculated using the number of times CIPN was documented as the denominator (n = 73).
b
Frequency (%) was calculated using the number of times CIPN was discussed as the denominator (n = 70).
c
Frequency (%) was calculated using the number of times participants reported CIPN as the denominator (n = 44)